VC-backed Arcadia Biosciences files for $86m IPO
Arcadia Biosciences, which wants to list on Nasdaq, is backed by BASF Venture Capital, Mandala Capital, CMEA Ventures and Saints Capital among others.
Arcadia Biosciences, which wants to list on Nasdaq, is backed by BASF Venture Capital, Mandala Capital, CMEA Ventures and Saints Capital among others.
Copyright PEI Media
Not for publication, email or dissemination